Riskpilot← Back to searchSign inGet full accessAB Carius Science Support
ABActiveOrg 5593079600Östra Spöland 10Regulation of health care, education, cultural services and other social services · NACE 8412Est. 20210 employees
Revenue 2024
SEK 313K
-26% vs 2023
EBITDA margin
60.3%
-44% vs 2023
Equity ratio
33.7%
Financial strength
Net profit 2024
SEK 100K
-62% vs 2023
| Revenue | SEK 313K | -26% |
| EBITDA | SEK 189K | -44% |
| Net profit | SEK 100K | -62% |
| Total assets | SEK 1,4M | +137% |
| Equity | SEK 465K | -17% |
| Employees | 0 | — |
Legal name
AB Carius Science Support
Org number
5593079600
Legal form
Aktiebolag
NACE code
8412 · Regulation of health care, education, cultural services and other social services
Founded
19 mars 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall tillhandahålla administrativt stöd till enheter som bedriver vetenskap och forskning, såsom universitet, företag och föreningar, äga och förvalta fastigheter och värdepapper samt därmed förenlig verksamhet.
Address
Östra Spöland 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 306 | 416 | 424 | 313 |
| Staff expenses | — | −9 | −9 | −1 |
| EBITDA | 294 | 298 | 338 | 189 |
| Depreciation & amort. | −0 | −8 | −12 | −23 |
| EBIT | 294 | 290 | 327 | 166 |
| Net financials | — | — | 1 | 0 |
| Profit before tax | 294 | 290 | 327 | 126 |
| Tax | −61 | −60 | −67 | −26 |
| Net profit | 233 | 230 | 260 | 100 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 284 | 516 | 583 | 1 381 |
| Equity | 258 | 488 | 561 | 465 |
| Long-term debt | 0 | — | — | 787 |
| Short-term debt | 25 | 28 | 22 | 88 |
| Total debt | 25 | 28 | 22 | 875 |
EBITDA margin
60.3%
This company
15.8%
Market median
+282% vs market
20212024
Equity ratio
33.7%
This company
38.2%
Market median
+12% vs market
20212024
Return on equity
21.5%
This company
18.4%
Market median
+17% vs market
20212024
Net profit margin
31.9%
This company
8.1%
Market median
+294% vs market
20212024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20212024
Debt / equity
1.97×
This company
0.62×
Market median
-218% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-03-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Carius Science Support also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Alexander Björk | Deputy Board Member | 0 companies |
| Anna Katrin Wallberg | Deputy Board Member | 0 companies |
| Therese Anna Maria Bratteberg | Board of Directors | 0 companies |
| Bror Roine Ingemar Ankarström | Deputy Board Member | 0 companies |
| Anke Berit Carius | Board of Directors | 0 companies |
| Matilda Margareta Bylund | Deputy Board Member | 0 companies |